Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
436.2 INR | +1.01% | +16.41% | +20.79% |
May. 29 | Solara Active Pharma Sciences Limited Re-Affirms Earnings Guidance for the Fiscal Year 2025 | CI |
May. 29 | Transcript : Solara Active Pharma Sciences Limited, Q4 2024 Earnings Call, May 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.79% | 248M | |
+48.53% | 779B | |
+40.67% | 631B | |
-6.37% | 354B | |
+20.93% | 333B | |
+8.21% | 301B | |
+16.75% | 249B | |
-1.19% | 216B | |
+10.85% | 214B | |
+4.40% | 163B |
- Stock Market
- Equities
- SOLARA Stock
- News Solara Active Pharma Sciences Limited
- Solara Active Pharma's Tamil Nadu Plant in India Clears US FDA Inspection